Brief: XBiotech Announces Oral Presentation Of Atopic Dermatitis Results For Bermekimab At 2019 EADV Congress In Madrid, Spain
27/09/2019 13:28
Sept 27 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH ANNOUNCES ORAL PRESENTATION OF ATOPIC DERMATITIS
RESULTS FOR BERMEKIMAB AT 2019 EADV CONGRESS IN MADRID, SPAIN
Source text for Eikon: ID:nGNE1nNlKR
Further company coverage: XBIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke